Compounds derived from Pyridine and pyrimidine tetrahidropirido - - tetrahidropirido, C5A receptor modulators； Pharmaceutical composition that comprises Pharmaceutical Combination； use； in the treatment of age-related Macular Degeneration, Diabetic Retinopathy, multiple sclerosis Ave, Parkinson's disease, Crohn's disease, among others.

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

GELIN CHRISTINE,ALEC FLYER,CHRISTOPHER MICHAEL ADAMS,VERONIQUE DARSIGNY,TIMOTHY BRIAN HURLEY,RAJESHRI GANESH KARKI,NAN JI,TOSHIO KAWANANI,ERIK MEREDITH,MICHAEL H SERRANO WU,CHANG RAO,CATHERINE SOLOVAY

申请号：

CL2014000171

公开号：

CL2014000171A1

申请日:

2014.01.22

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.COMPUESTOS DERIVADOS DE 5,6,7,8-TETRAHIDROPIRIDO-[4,3-D]PIRIDINA Y 5,6,7,8-TETRAHIDROPIRIDO-[4,-D]-PIRIMIDINA, MODULADORES DE RECEPTORES DE C5A； COMPOSICION FARMACEUTICA； COMBINACIONES FARMACEUTICAS； SUS USOS, UTILES PARA EL TRATAMIENTO DE DEGENERACION MACULAR RELACIONADA CON LA EDAD, RETINOPATIA DIABETICA, ESCLEROSIS MULTIPLE, AVE, ENFERMEDAD DE CROHN, ENTRE OTRAS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/